PATENT CLAIM ANALYSIS

Application Number: 16049541
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["435", "006100"]

Abstract:
FRET-labeled compounds are provided for use in analytical reactions. In certain embodiments, FRET-labeled nucleotide analogs are used in place of naturally occurring nucleoside triphosphates or other analogs in analytical reactions comprising nucleic acids, for example, template-directed nucleic acid synthesis, DNA sequencing, RNA sequencing, single-base identification, hybridization, binding assays, and other analytical reactions.

Claim (Index 26):
The kit of  claim 22 , wherein the kit further comprises at least a third nucleotide analog, the third nucleotide analog comprising a third fluorescent label producing a third signal in response to excitation illumination, the third signal differing from each of the first and second signals by at least one of its emission intensity and its emission spectrum.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.53659
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15379118', '13427611', '12749859', '14633094', '12967507']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6245867192067658
- 35 USC 102 Novelty (BERT): 0.5911753332326153
- Combined Prediction Score: 0.6212455806093508
- Mean Citation Score: 420.443488
- Max Citation Score: 523.9585
- Similarity Product: 433.8467620122135

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test